It was Phase I/II and they were and are testing efficacy. I think the issue is the ongoing assessment and as I noted, lack of detail around efficacy. So further results on efficacy are due by end of Q2...
It was Phase I/II and they were and are testing efficacy. I...
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.5¢ | 5.3¢ | $33.62K | 629.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3755572 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 120107 | 3 |
View Market Depth
| Last trade - 14.27pm 08/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |